HighLife Medical Secures $90 Million in Funding
HighLife Medical, a Paris-based company focused on providing innovative treatment options for heart valve diseases, has successfully raised $90 million in a recent funding round. This financial boost is aimed at advancing its clinical development program in the United States and expanding its commercial activities in Europe.
Investment Details
The funding round, whose specific stage was not disclosed, was co-led by prominent investors including Andera Partners, Sofinnova Partners, Supernova Invest, and Mérieux Equity Partners. Additional support came from BNP Paribas Développement, Capricorn Partners, Critical Path Ventures, Pro Benefis Familiae, SPRIM Global Investments, a global strategic investor, USVP, Sectoral, and VI Partners.
Strategic Use of Funds
The newly acquired funds will primarily be directed towards enhancing HighLife Medical's Transcatheter Mitral Valve Replacement (TMVR) system. This system is designed for patients suffering from significant mitral regurgitation who are unsuitable for traditional surgery or other transcatheter procedures. The financing will support the expansion of HighLife's European commercial operations and the advancement of its pivotal U.S. clinical study.
Recent Milestones
HighLife Medical has achieved several key milestones in 2026. In January, the company received CE Mark approval for its TMVR system, enabling a limited commercial launch in Europe and the initiation of a pivotal clinical study in the U.S. Furthermore, in July, HighLife received CE Mark approval for its next-generation Clarity Valve, which aims to address challenges such as left ventricular outflow tract obstruction in mitral valve replacement procedures.
Leadership Insights
Malek Nasr, a medtech entrepreneur and co-founder of HighLife, has been instrumental in steering the company towards its strategic goals. While specific quotes from Nasr were not available, his leadership continues to guide HighLife's mission to offer less invasive treatment options for heart valve diseases, enhancing patient outcomes.
For more information, visit HighLife Medical's website.